Harare
President Emmerson Mnangagwa on Wednesday got a jab in Victoria Falls, in western Zimbabwe, to promote tourism and launch the second phase of the country's vaccination drive. Mnangagwa's injection was broadcast live on national TV.
Zimbabwe purchased 200,000 doses of the Sinovac vaccine which arrived from China earlier this month. China has also donated 400,000 Sinopharm doses. Currently, the two Chinese vaccines are the only ones in Zimbabwe.
The first phase of Zimbabwe's vaccination campaign, which relied on Sinopharm, targeted front-line workers such as health care workers, border officials, gravediggers, and journalists.
Just over 44,000 people in Zimbabwe have been vaccinated so far, representing 68% of the target population for the first phase, said Mnangagwa, who described the figure as showing “broad acceptance” of the Chinese vaccine. But representatives of health workers say skepticism remains.
Zimbabwe's second phase is targeting schoolteachers, religious leaders, security forces, the elderly, and people with chronic diseases, said Mnangagwa.
However, the government made an exception in Victoria Falls, where it has invited all of the town's 110,000 residents to get inoculated in order to “pave the way for unlimited tourism activities” in the country's prime attraction, said Mnangagwa.
The vaccines that Zimbabwean health authorities have approved for use include the Sinopharm and Sinovac vaccines from China, for use, Russia's Sputnik-V, and India's Covaxin, although only the Chinese vaccines have arrived in this southern African country.
Zimbabwe aims to vaccinate 10 million of its people, representing 60% of the country's population, in an effort to achieve herd immunity, which is when enough people have immunity, either from vaccination or past infection, to stop the uncontrolled spread of a virus.
Zimbabwe has recorded 36,717 cases of infection, including 1,516 deaths, by Mar.23, according to the health ministry.
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android